1. Home
  2. IMRN vs SMTK Comparison

IMRN vs SMTK Comparison

Compare IMRN & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • SMTK
  • Stock Information
  • Founded
  • IMRN 1994
  • SMTK 2009
  • Country
  • IMRN Australia
  • SMTK United Kingdom
  • Employees
  • IMRN N/A
  • SMTK N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • SMTK
  • Sector
  • IMRN Health Care
  • SMTK
  • Exchange
  • IMRN Nasdaq
  • SMTK NYSE
  • Market Cap
  • IMRN 15.0M
  • SMTK 13.3M
  • IPO Year
  • IMRN N/A
  • SMTK N/A
  • Fundamental
  • Price
  • IMRN $2.15
  • SMTK $3.72
  • Analyst Decision
  • IMRN Strong Buy
  • SMTK
  • Analyst Count
  • IMRN 1
  • SMTK 0
  • Target Price
  • IMRN $5.00
  • SMTK N/A
  • AVG Volume (30 Days)
  • IMRN 21.6K
  • SMTK 109.9K
  • Earning Date
  • IMRN 02-26-2025
  • SMTK 02-12-2025
  • Dividend Yield
  • IMRN N/A
  • SMTK N/A
  • EPS Growth
  • IMRN N/A
  • SMTK N/A
  • EPS
  • IMRN N/A
  • SMTK N/A
  • Revenue
  • IMRN $3,271,194.00
  • SMTK $40,000.00
  • Revenue This Year
  • IMRN N/A
  • SMTK N/A
  • Revenue Next Year
  • IMRN N/A
  • SMTK N/A
  • P/E Ratio
  • IMRN N/A
  • SMTK N/A
  • Revenue Growth
  • IMRN 171.67
  • SMTK 471.43
  • 52 Week Low
  • IMRN $1.59
  • SMTK $2.01
  • 52 Week High
  • IMRN $5.96
  • SMTK $13.00
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 56.18
  • SMTK N/A
  • Support Level
  • IMRN $1.85
  • SMTK N/A
  • Resistance Level
  • IMRN $2.20
  • SMTK N/A
  • Average True Range (ATR)
  • IMRN 0.22
  • SMTK 0.00
  • MACD
  • IMRN 0.01
  • SMTK 0.00
  • Stochastic Oscillator
  • IMRN 57.47
  • SMTK 0.00

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About SMTK SMARTKEM INC

SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.

Share on Social Networks: